Sign in
4

Changes in Ownership

Elanco Animal Health Inc Filed Acc 0001415889-24-012472

Options or other derivatives

  • PRESIDENT, CEO AND DIRECTOR acquired 204.67 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Simmons Jeffrey N · PRESIDENT, CEO AND DIRECTOR

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-05-03 Grant or award : show line 1 in the form Deferred Stock Units +204.67 $13.53 $2,769 1,642.96 D
Loading xslF345X05/form4-05072024_080527.xml…